TF’s anti-inflammatory effects were evident in the reduction in CRS-induced inflammatory markers, including CXCL2, iNOS, and IFNG, which are linked to systemic and neuroinflammation [49]. The gene discussed is CXCL2; the disease is congenital rubella syndrome.